Publication:
Roles of glutamate in brain injuries after subarachnoid hemorrhage

Thumbnail Image
Files
Kawakita-37-1041-1051-2022.pdf(2.54 MB)
Date
2022
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Kawakita, Fumihiro ; Kanamaru, Hideki ; Asada, Reona ; Suzuki, Yume ; Nampei, Mai ; Nakajima, Hideki ; Oinaka, Hiroki ; Suzuki, Hidenori
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-509
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Aneurysmal subarachnoid hemorrhage (SAH) is a stroke type with a high rate of mortality and morbidity. Post-SAH brain injury as a determinant of poor outcome is classified into the following two types: early brain injury (EBI) and delayed cerebral ischemia (DCI). EBI consists of various acute brain pathophysiologies that occur within the first 72 hours of SAH in a clinical setting. The underlying mechanisms of DCI are considered to be cerebral vasospasm or microcirculatory disturbance, which develops mostly 4 to 14 days after clinical SAH. Glutamate is the principal neurotransmitter in the central nervous system, but excessive glutamate is known to induce neurotoxicity. Experimental and clinical studies have revealed that excessive glutamates are released after SAH. In addition, many studies have reported the relationships between excessive glutamate release or overactivation of glutamate receptors and excitotoxicity, cortical spreading depolarization, seizure, increased blood-brain barrier permeability, neuroinflammation, microthrombosis formation, microvasospasm, cerebral vasospasm, impairments of brain metabolic supply and demand, impaired neurovascular coupling, and so on, all of which potentially contribute to the development of EBI or DCI. As glutamates always exert their functions through one or more of 4 major receptors of glutamates, it would be valuable to know the mechanisms as to how glutamates cause these pathologies, and the possibility that a glutamate receptor antagonist may block the pathologies. To prevent the mechanistic steps leading to glutamatemediated neurotoxicity may ameliorate SAH-induced brain injuries and improve the outcomes. This review addresses the current knowledge of glutamate-mediated neurotoxicity, focusing on EBI and DCI after SAH.
publication.page.subject
Cerebral vasospasm , Cortical spreading depolarization , Delayed cerebral ischemia , Early brain injury , Glutamate , Neurovascular coupling , Subarachnoid hemorrhage
Citation
Histology and Histopathology Vol. 37, nº11 (2022)
URI
http://hdl.handle.net/10201/129123
item.page.embargo
Collections
Histology and histopathology Vol.37,nº11 (2022)
Ir a Estadísticas